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Abstract
Background: Adhesive Capsulitis (AC) affects patient of all ages, and stretching protocols are
commonly prescribed for this condition. Dynamic splinting has been shown effective in contracture
reduction from pathologies including Trismus to plantar fasciitis. The purpose of this study was to
examine the efficacy of dynamic splinting on patients with AC.
Methods: This controlled, cohort study, was conducted at four physical therapy, sports medicine
clinics in Texas and California. Sixty-two patients diagnosed with Stage II Adhesive Capsulitis were
grouped by intervention. The intervention categories were as follows: Group I (Control); Group
II (Physical Therapy exclusively with standardized protocols); Group III; (Shoulder Dynasplint
system exclusively); Group IV (Combined treatment with Shoulder Dynasplint and standardized
Physical Therapy). The duration of this study was 90 days for all groups, and the main outcome
measures were change in active, external rotation.
Results: Significant difference was found for all treatment groups (p < 0.001) following a one-way
ANOVA. The greatest change with the smallest standard deviation was for the combined
treatment group IV, (mean change of 29°).
Conclusion:  The difference for the combined treatment group was attributed to patients'
receiving the best PT combined with structured "home therapy" that contributed an additional 90
hours of end-range stretching. This adjunct should be included in the standard of care for adhesive
Capsulitis.
Trial Registration: Trial Number: NCT00873158
Background
Adhesive capsulitis (AC) is an idiopathic disease that
affects an estimated 2-6% of the American population (6
to 18 million Americans) [1-6]. It is characterized by
fibrosis, decreased volume of the glenoid capsule, pain,
and progressive pain with loss of both active and passive
Range of Motion (ROM). The direct cost of treating this
pathology in the United States in the year 2000 was $7 bil-
lion [7] and it affects patients predominantly over 50
years of age.
This condition therefore is a serious pathology, which is
also known as "Frozen Shoulder" with three phases: 1)
The Painful stage is characterized by the gradual onset of
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diffuse shoulder pain and which usually lasts one to two
months; 2) The Frozen stage is characterized by progres-
sive loss of motion (particularly glenohumeral external
rotation) which lasts several months to a year or longer
[8]. This stage also exhibits decreased capsular volume
which can be visualized with MRI, for differential diagno-
sis; 3) The Thawing stage is the final stage during which
range of motion gradually improves over several months
to years. Range of motion deficits may continue to be
unresolved for more than 3-5 years following the onset of
AC.
Contracture is defined as shortening of connective tissue
(ligaments, tendons, and cartilage) caused by excessive
arthrofibrosis, immobilization, inactivation, adhesions,
or excessive neuromuscular tone [9-11]. Contracture in
the shoulder is primarily seen in decreased capsular vol-
ume, and is measured with MRI for differential diagnosis.
There are many treatment methods for adhesive capsulitis
including physical therapy, corticosteroid injections
(intra-articular), hydroplasty, manipulation of the joint
while under anesthetics and surgery [1-3,5-8,11-20]. The
conservative primary treatment for adhesive capsulitis are
intra-articular corticosteroid injections and physical ther-
apy, which was examined by Dudkiewicz et al. [8]. They
conducted a long-term follow-up (mean 9.2 years) of 54
patients suffering from idiopathic adhesive capsulitis, and
their results showed that conservative treatment alone
(physical therapy and non-steroidal anti-inflammatory
medications) was an effective, long-term treatment
method.
Current Treatments for AC range from surgical interven-
tion or manipulation under anesthetics [21], stretching
protocols combined with glenohumeral intra-articular
corticosteroid injections [22], and continuous passive
motion devices [23]. Studies of often report benefits from
early intervention [7,12,22] which Earley and Shannon
said may help prevent the "downward spiral of forced dis-
use" leading to contracture [7]. Joint mobilization and
flexibility training are common features in treatment of
this condition.
Griggs, et al. revealed in a prospective study that showed a
significant benefit from participating in a "Four-direction
shoulder-stretching exercise program"[12]. In their study,
75 patients diagnosed with Stage II idiopathic adhesive
capsulitis participated, and 90% of the patients were satis-
fied with the outcome of the four-direction shoulder-
stretching exercise program. As a long-term study, (ROM
measurements were taken at 3, 6, 12,18, and 22 months)
ninety percent of the patients gained significant increases
in ROM of external rotation, internal rotation, flexion and
abduction in the first few months and maintained the
ROM through a daily four-direction shoulder-stretching
exercise program.
The protocol of using low-load prolonged-duration
stretch, combined with the therapeutic principle of
increased time at end range allows the patient to reduce
contracture by achieving permanent elongation of con-
nective tissue [9,10,13,14,24]. The protocol of increasing
total end range time has been shown to be beneficial,
despite the cause of contracture in the shoulder joint
[7,9,10,25,26]. This is the protocol used with the Dynas-
plint Systems, (Dynasplint Systems, Inc., Severna Park,
MD) and twenty-five years ago a biomechanically correct
device was developed to utilize a low-load prolonged-
duration stretch with dynamic tension to reduce contrac-
ture of the elbow and knee joints [10,24]. This stretching
protocol was subsequently included in the Shoulder
Dynasplint systems (SDS) modality which allows patients
to stretch in flexion, abduction, external, or internal rota-
tion.
The SDS is often prescribed as home therapy because it
designed to help the patient stretch the shoulder in multi-
ple planes. (See figure 1.) The purpose of this study was to
examine the efficacy of dynamic splinting with low-load,
prolonged-duration of stretching on adhesive capsulitis.
This study used a three-month duration which measured
change in the active external rotation of the shoulder,
(supine position with humerus abducted to 90°) which is
the most common ROM deficit in AC [2,3,5].
Methods
Subjects
Sixty-two patients between the ages of 36 and 75 with
Stage II adhesive capsulitis were prospectively recruited by
Dynasplint Shoulder System in External Rotation Figure 1
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referral from clinicians in California and Texas (Mean age
55.6 ± 7.9) and all patients had deficits in external rota-
tion. All patients enrolled had been previously treated
with cortical steroid injection(s) but no patients had pre-
viously undergone manipulation or surgery. Patients were
give informed consent and all patients' rights, protection,
and privacy have been ensured in this study as required by
the Gaspar-PT Biomed IRB and ethical approval was
received from this IRB. Patients were independently pre-
scribed treatment in one of the following groups:
￿ Group I was the control group, and these patients
were only treated with cortical steroid injections, (n =
15).
￿ Group II patients were treated exclusively with stand-
ardized physical therapy, twice per week, (n = 15).
￿ Group III patients were treated exclusively with the
SDS as "home therapy," (n = 16).
￿ Group IV patients were treated with both physical
therapy (twice weekly) and the SDS for daily end-
range stretching, (n = 16).
When enrolled, patients were instructed that if they
required additional treatment such as additional cortical
steroid injections then their participation in this study
would be completed but only two patients required such
additional treatment methods. Standardized Training and
reporting was used for all patients in all groups. All subject
data was transmitted in confidential documents without
jeopardizing the patients' privacy according to the federal
health information privacy protection act.
Clinical Protocols
All treatment categories were prescribed by the attending
physicians rather than being randomized, which may
reflect current treatments in use. Physical therapy was
standardized, based on the protocols of Vermuelen, Hsu,
and Mulligan.[4,6,16,17] These methods included moist
heat, patient education and re-evaluation of symptoms,
joint mobilization (limited to progressive end-range joint
mobilization), passive range of motion, AROM and PNF,
and therapeutic exercise. Group II and Group IV patients
participated in physical therapy for two or more times per
week, and the SDS was worn twice a day, seven days per
week.
Group III and Group IV patients who wore the SDS
received a standardized treatment protocol and wearing
schedule. These patients were instructed on the use by the
by the physical therapist and a Dynasplint consultant who
accomplished a customized fitting of the unit and taught
the standardized protocol regarding how to increase ten-
sion in the direction of external rotation, with humeral
abduction to 90 degrees. Each subject was instructed to fax
a weekly tracking form to investigators which reported
daily duration(s) in the SDS and tension settings used.
Patients were instructed to begin the dynamic splinting
with only the tension setting of #1 for the first week for
accommodation, and then they increase the tension set-
ting to #2 which equals 3.0 foot pounds of force. During
this period, patients were instructed to increase the dura-
tion in the SDS unit for 20-30 minutes, twice each day
(with the goal of stretching 60 total minutes per day).
If the patient had post-wear discomfort or stiffness lasting
more than one hour after removing the splint, the dura-
tion of the treatment was then reduced for the next two
scheduled stretching bouts. After the patient was able to
tolerate 60 minutes of stretching, (30 min, bid) then the
patient was then instructed to increase the tension every
two weeks as tolerated, without discomfort lasting more
than one hour following each stretching session.
After 90 consecutive days in the SDS the patients' Active
External Rotation was measured again by the same, pre-
scribing clinician. While treatment with the SDS may be
performed in multiple planes, this study chose to only
evaluate ER rotation because it is the most common
restricted ROM from Adhesive Capsulitis [5-7]. Analysis
of "Intention to Treat" include the data from patients who
were non-compliant (less than 90% PT attendance and/or
less than 90% scheduled use of SDS) or did not complete
the study duration. All patients' data was included in this
analysis.
Data Analysis
The dependent variable was the change in Active Range of
Motion, Supine External Rotation (Humerus abducted to
90°), and the independent variables were groups (Con-
trol vs. Physical therapy vs. SDS vs. Combined SDS and
Physical Therapy). One-Way Analyses Of Variance
(ANOVA) was performed using the Graph-Pad, InStat
software, and post-hoc T-tests were performed to measure
difference between groups. (An alpha level of 0.05 was
used for all tests.) All other calculations were made with
the Microsoft Excel program.
Equipment Used
Dynasplint® Shoulder System
Dynasplint Systems, Inc.
770 Ritchie Highway, Suite W21
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800-638-6771
Dynasplint® and Dynasplint Shoulder System
Are registered trademarks of Dynasplint Systems, Inc.
In-Stat Software
2055 Gateway Place, Suite 150
San Jose CA 95110
408-345-4495
Results
There was a significant difference for each treatment
groups (PT Only: T = 4.441, P < 0.001; SDS Only: T =
4.887, P < 0.001; Combined: T = 5.318, P < 0.001). Due
to the low power there was not a significant difference
between treatment groups but the greatest change and the
smallest Standard Deviation was seen for the Combined
Treatment Group PT + SDS (mean 29.8° of change and
SD = 12.36; see Figure 2.) This suggests that the SDS is a
measurably effective adjunct to physical therapy as a struc-
tured home therapy. (See Table 1.)
Discussion
The purpose of this study was to examine the efficacy of
dynamic splinting on adhesive capsulitis in a prospective,
cohort study. Although dynamic splinting for other
extremity joints have been studied [10,24], this is the first
controlled study investigating the effects of the dynasplint
shoulder system. The results showed the efficacy of
dynamic splinting as an effective "home therapy" adjunct
to physical therapy. The additional 80 to 90 hours of end-
range stretching as home therapy combined with stand-
ardized physical therapy is considered to be responsible
for the greatest change in AROM of external rotation.
The results were in agreement with the study by Griggs et.
al. [9], which demonstrated that a conservative treatment
protocol of four-direction shoulder-stretching exercise
program would benefit shoulder flexibility. This experi-
ment also confirmed the findings of Dudkiewicz et al.[6]
which described the efficacy of "conservative protocols."
Because ROM deficits frequently exist in external rotation,
this experiment chose to examine only that plane follow-
ing treatment with physical therapy and/or the SDS.
Conclusion
Use of the SDS may be an effective adjunct "home ther-
apy" for adhesive capsulitis, and the additional 60 min-
utes per day of low-load, prolonged-stretch was beneficial.
(The mean time recorded was 85 hours in this 90 days
study.) Earley and Shannon [7] proposed that conserva-
tive interventions of adhesive capsulitis would be the
most beneficial when initiated as soon as the diagnosis is
made, and DS could be an effective initial modality of
conservative treatment.
Confounding variables in this study included lack of ran-
domization. Grouping was done by the prescribing clini-
cian who may have been biased, based on patient history.
The total duration that each patient endured Stage II of
adhesive capsulitis was not differentiated. Limitations of
this study also included that it was only performed on a
small number of patients and was limited to examining
the Active Range of Motion, Supine External Rotation
(Humerus abducted to 90°).
A future study comparing the duration of treatment to dis-
charge between groups would be greatly beneficial in
Graph displaying the results of the study Figure 2
Graph displaying the results of the study.
Table 1: Active Range of Motion in External Rotation
Control PT Only SDS Only Combined
Initial Final Initial Final Initial Final Initial Final
Mean 39.3 47.6 38.3 64.0 38.9 65.3 40.8 70.6
SD 15.3 15.6 15.3 15.5 15.3 20.3 15.1 15.1
N 15 15 16 16BMC Musculoskeletal Disorders 2009, 10:111 http://www.biomedcentral.com/1471-2474/10/111
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measuring the benefits that the SDS has in treating adhe-
sive capsulitis. A larger subject population would reduce
the chance for type two error, and a randomized, control-
led trial would eliminate most of the limitations discussed
regarding this study. A pain scale should also be used in
the next study.
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